• Publications
  • Influence
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
PURPOSE An increasing serum prostate-specific antigen (PSA) level is the initial sign of recurrent prostate cancer among patients treated with radical prostatectomy. Salvage radiation therapy (SRT)Expand
  • 758
  • 40
Gene expression profiling predicts clinical outcome of prostate cancer.
One of the major problems in management of prostate cancer is the lack of reliable genetic markers predicting the clinical course of the disease. We analyzed expression profiles of 12,625 transcriptsExpand
  • 454
  • 24
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
PURPOSE The long-term risk of prostate cancer-specific mortality (PCSM) after radical prostatectomy is poorly defined for patients treated in the era of widespread prostate-specific antigen (PSA)Expand
  • 381
  • 20
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
PURPOSE A postoperative nomogram for prostate cancer recurrence after radical prostatectomy (RP) has been independently validated as accurate and discriminating. We have updated the nomogram byExpand
  • 561
  • 16
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
CONTEXT Salvage radiotherapy may potentially cure patients with disease recurrence after radical prostatectomy, but previous evidence has suggested that it is ineffective in patients at the highestExpand
  • 406
  • 15
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
PURPOSE Prostate-specific antigen (PSA) defined biochemical recurrence (BCR) of prostate cancer is widely used for reporting the outcome of radical prostatectomy (RP). A standardized BCR definitionExpand
  • 398
  • 15
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
An existing preoperative nomogram predicts the probability of prostate cancer recurrence, defined by prostate-specific antigen (PSA), at 5 years after radical prostatectomy based on clinical stage,Expand
  • 501
  • 14
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.
PURPOSE Positive surgical margins increase the risk of biochemical recurrence after radical prostatectomy by 2 to 4-fold. The risk of biochemical recurrence may be influenced by the anatomicalExpand
  • 146
  • 12
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
PURPOSE Long-term prostate cancer specific mortality after radical prostatectomy is poorly defined in the era of widespread screening. An understanding of the treated natural history of screenExpand
  • 491
  • 11
American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors.
PURPOSE To provide recommendations on appropriate uses for serum markers of germ cell tumors (GCTs). METHODS Searches of MEDLINE and EMBASE identified relevant studies published in English. PrimaryExpand
  • 147
  • 11